The effectiveness and safety comparison of hypavazole and propyphenols are used for the effectiveness and safety of the painless gastroscopy examination of obese patients, respectively

No opioidized anesthesia for the effectiveness and safety of gastroscopy for obese patients

Status

Recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2200065575

Enrollment

Unknown

Registered

2022-11-09

Start date

2022-09-23

Completion date

Unknown

Last updated

2023-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastrointestinal

Interventions

P group:propofol+esketamine

R group:remimazolam+esketamine

Eligibility

Sex/Gender

All

Age

18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Obese patients undergoing painless gastroscopy 2. Sign the informed consent form and voluntarily participate in this experiment, 3. ASA grade I-II 4. The patient's body mass index is between 30-40kg/m2 5. The age of the patient is between 18-65 years old

Exclusion criteria

Exclusion criteria: 1. Patients with central nervous system or psychiatric diseases and taking psychiatric drugs before surgery 2. Patients who are allergic to related anesthetic drugs 3. The patient has a history of gastroscopy in the past 4. The patient has severe cardiohepatic and renal insufficiency 5. The patient has a pronounced difficult airway (modified Mallampati class IV)

Design outcomes

Primary

Measure	Time frame
incidence of Hypoxemia;	—

Secondary

Measure	Time frame
Induction time;Time to anesthesia recovery;any postoperative adverse reactions;	—

Countries

China

Contacts

Public ContactGao Fang

gaofangxz@126.com+86 18052268331

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 9, 2026